EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Effect of Statins in Patients With Hemodialysis‐Dependent Chronic Kidney Disease: A Nationwide Cohort Study

Minyoul Baik iD, Jimin Jeon iD, Joonsang Yoo iD, Jinkwon Kim iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.043214 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Minyoul Baik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Yongin Severance Hospital Yonsei University College of Medicine Yongin-si Gyeonggi-do South Korea. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Renal Dialysis, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Guidelines for lipid‐lowering therapy in patients with dialysis‐dependent chronic kidney disease remain ambiguous. We aimed to explore cardiovascular outcomes associated with statin use in patients with hemodialysis‐dependent chronic kidney disease, stratified by prior statin use.

Methods

This was a retrospective cohort study of patients with chronic kidney disease who initiated maintenance hemodialysis, using a nationwide health claims database in Korea between 2010 and 2021. A multivariate Cox regression analysis was performed, incorporating statin use throughout the follow‐up period as a time‐dependent variable. The primary outcome was a composite of stroke, myocardial infarction, and all‐cause mortality. A subgroup analysis was conducted based on statin use before hemodialysis initiation.

Results

Of the 49 868 study participants, the mean age at hemodialysis initiation was 65.5±11.2 years, and 32 225 (64.6%) were men. During a mean follow‐up of 3.8 years, the primary composite outcome occurred in 20 345 patients (40.8%). Throughout the follow‐up period, approximately 40% of patients received statin therapy. Statin use was significantly associated with a reduced risk of the primary composite outcome (adjusted hazard ratio, 0.51 [95% CI, 0.49–0.53]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsRenal DialysisRenal Insufficiency, ChronicCardiovascular DiseasesHumansMaleFemaleAgedRetrospective StudiesMiddle AgedRepublic of KoreaRisk FactorsTreatment OutcomeTime Factors

Stichwörter der Autor:innen

cardiovascular outcomechronic kidney diseasehemodialysisstatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Neurology, Yongin Severance Hospital Yonsei University College of Medicine Yongin-si Gyeonggi-do South Korea.

ORCID-Profile: Minyoul Baik, Jimin Jeon, Joonsang Yoo, Jinkwon Kim

Zitieren

APA

Baik, M., Jeon, J., Yoo, J., & Kim, J. (2025). Effect of Statins in Patients With Hemodialysis‐Dependent Chronic Kidney Disease: A Nationwide Cohort Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043214

Vancouver

Baik M, Jeon J, Yoo J, Kim J. Effect of Statins in Patients With Hemodialysis‐Dependent Chronic Kidney Disease: A Nationwide Cohort Study. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.043214

BibTeX
@article{Baik2025,
  author = {Baik, Minyoul and Jeon, Jimin and Yoo, Joonsang and Kim, Jinkwon},
  title = {Effect of Statins in Patients With Hemodialysis‐Dependent Chronic Kidney Disease: A Nationwide Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.043214}
}
Kostenlos starten →